Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Options trading offers unique opportunities to boost investment returns. Discover how to leverage options for greater gains.
25,570 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Fresh Epstein files are prompting urgent questions about governance and accountability as executives connected to the...
A newCapital Economics note warns that the current rotation in U.S. equities could be a forerunner to a broader corre...
Lowe’s beat on near-term earnings but issued a muted FY26 outlook, sending its stock lower while TJX jumped on strong...
Fed minutes reveal a widening rift among policymakers: while the Fed kept rates steady, some officials signaled possi...
Stratasys is stepping into 2025 with a focused plan to diversify revenue, improve margins, and scale software-led ser...
Target unveiled a bold turnaround, but questions linger about what Target's Michael Fiddelke may be missing about eve...
Institutional demand for Solana ETFs has reached about $540 million across roughly 30 institutions, even as SOL trade...
Sheryl Sandberg delivers a blunt critique of Silicon Valley's workplace climate, calling hypermasculine rhetoric amon...
Disney moved to strengthen its finances ahead of a CEO transition by extending CFO Hugh Johnston's contract, signalin...
Markets brace for a year where prices rise while growth falters. This report explains why stagflation: word year 2026...
Volatility is rising and daily balance checks may hurt more than help. This piece explains why experts stop checking ...